Philip Mitchelmore

2.4k total citations
16 papers, 111 citations indexed

About

Philip Mitchelmore is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Speech and Hearing. According to data from OpenAlex, Philip Mitchelmore has authored 16 papers receiving a total of 111 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 3 papers in Speech and Hearing. Recurrent topics in Philip Mitchelmore's work include Cystic Fibrosis Research Advances (8 papers), Tracheal and airway disorders (5 papers) and Respiratory viral infections research (3 papers). Philip Mitchelmore is often cited by papers focused on Cystic Fibrosis Research Advances (8 papers), Tracheal and airway disorders (5 papers) and Respiratory viral infections research (3 papers). Philip Mitchelmore collaborates with scholars based in United Kingdom, Switzerland and Romania. Philip Mitchelmore's co-authors include David L. Smith, Najib M. Rahman, Timothy Collyns, Simon P. Hart, Jelena Savović, Martha Elwenspoek, Sarah Dawson, Alan R. Brown, Chris J. Scotton and Nicholas Withers and has published in prestigious journals such as Thorax, Clinical Microbiology and Infection and Diagnostic Microbiology and Infectious Disease.

In The Last Decade

Philip Mitchelmore

13 papers receiving 108 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Mitchelmore United Kingdom 5 60 42 26 11 11 16 111
Xiudi Han China 9 37 0.6× 123 2.9× 11 0.4× 3 0.3× 55 5.0× 30 167
Andrea Browatzki Denmark 8 134 2.2× 31 0.7× 58 2.2× 3 0.3× 11 1.0× 14 198
Xiaomai Wu China 7 36 0.6× 36 0.9× 7 0.3× 7 0.6× 71 6.5× 19 155
Guadalupe Bermudo Spain 8 112 1.9× 90 2.1× 51 2.0× 1 0.1× 9 0.8× 19 206
Zhiqiang Zhuo China 7 46 0.8× 65 1.5× 2 0.1× 5 0.5× 12 1.1× 25 158
Kim Horne Australia 6 11 0.2× 31 0.7× 11 0.4× 4 0.4× 7 0.6× 9 142
Eun Ae Yang South Korea 8 34 0.6× 155 3.7× 9 0.3× 1 0.1× 11 1.0× 20 214
Charlotte Thibeault Germany 5 46 0.8× 23 0.5× 9 0.3× 8 0.7× 65 5.9× 11 168
Øistein Svanes Norway 7 61 1.0× 16 0.4× 24 0.9× 1 0.1× 10 0.9× 13 128
Clare Halfhide United Kingdom 4 59 1.0× 85 2.0× 17 0.7× 21 1.9× 8 111

Countries citing papers authored by Philip Mitchelmore

Since Specialization
Citations

This map shows the geographic impact of Philip Mitchelmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Mitchelmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Mitchelmore more than expected).

Fields of papers citing papers by Philip Mitchelmore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Mitchelmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Mitchelmore. The network helps show where Philip Mitchelmore may publish in the future.

Co-authorship network of co-authors of Philip Mitchelmore

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Mitchelmore. A scholar is included among the top collaborators of Philip Mitchelmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Mitchelmore. Philip Mitchelmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Mitchelmore, Philip, et al.. (2024). Culture-independent Multilocus sequence typing screening for Haemophilus influenzae cross-infection in non-cystic fibrosis bronchiectasis. Diagnostic Microbiology and Infectious Disease. 110(1). 116327–116327.
2.
Mitchelmore, Philip, et al.. (2024). Comparison of Reporting Quality in National Cystic Fibrosis Patient Registries: Implications for Identifying Use of Novel CFTR Modulators. Pulmonary Therapy. 10(4). 427–438. 1 indexed citations
3.
Morelli, Thiago, Martha Purcell, Peter Lee, et al.. (2024). P2 Respiratory syncytial virus (RSV) infection in hospitalised adults: who should be vaccinated?. A109.1–A109.
4.
5.
Mitchelmore, Philip, et al.. (2021). ERS ECM Awardee 2021, a preview of LSC 2022 and a brief overview of the Respiratory Channel. Breathe. 17(4). 210121–210121. 1 indexed citations
6.
7.
Mitchelmore, Philip, Nicholas Withers, Christopher Sheldon, Chris J. Scotton, & Alan R. Brown. (2021). Culture-independent multilocus sequence typing of Pseudomonas aeruginosa for cross-infection screening. Diagnostic Microbiology and Infectious Disease. 100(1). 115315–115315. 5 indexed citations
8.
Smith, David L., et al.. (2020). British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease. Thorax. 75(5). 370–404. 35 indexed citations
9.
10.
Smith, David L., et al.. (2020). British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease. BMJ Open Respiratory Research. 7(1). e000489–e000489. 27 indexed citations
11.
Mitchelmore, Philip, et al.. (2018). Risk of Bacterial Transmission in Bronchiectasis Outpatient Clinics. PubMed. 7(3). 72–78. 3 indexed citations
12.
Mitchelmore, Philip, Martin H. Dawson, S. Jones, et al.. (2018). P72 Outcomes and patient satisfaction from an established virtual pulmonary nodule clinic. A140.2–A141. 1 indexed citations
13.
Mitchelmore, Philip, Matthew Bull, Karen Moore, et al.. (2017). Molecular epidemiology of Pseudomonas aeruginosa in an unsegregated bronchiectasis cohort sharing hospital facilities with a cystic fibrosis cohort. Thorax. 73(7). 677–679. 9 indexed citations
14.
Mitchelmore, Philip, Alan R. Brown, Christopher Sheldon, et al.. (2015). S113 An Epidemiological Review of Strains of Pseudomonas aeruginosa in a Non-Cystic Fibrosis Bronchiectasis Cohort. Thorax. 70(Suppl 3). A65.1–A65. 1 indexed citations
15.
Mitchelmore, Philip, et al.. (2013). P115 Epidemiology, Characteristics and Management of Non Tuberculous Mycobacteria in a Devon Population. Thorax. 68(Suppl 3). A126.2–A127. 1 indexed citations
16.
Mitchelmore, Philip, Christopher Sheldon, & Nicholas Withers. (2013). P105 Outpatient survey of patient experience of hypertonic saline use in non-cystic fibrosis bronchiectasis. Thorax. 68(Suppl 3). A122.1–A122.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiudi Han Breakdown of academic impact, for papers by Andrea Browatzki Breakdown of academic impact, for papers by Xiaomai Wu Breakdown of academic impact, for papers by Guadalupe Bermudo Breakdown of academic impact, for papers by Zhiqiang Zhuo Breakdown of academic impact, for papers by Kim Horne Breakdown of academic impact, for papers by Eun Ae Yang Breakdown of academic impact, for papers by Charlotte Thibeault Breakdown of academic impact, for papers by Øistein Svanes Breakdown of academic impact, for papers by Clare Halfhide
Rankless by CCL
2026